Back to Search
Start Over
Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea
- Source :
- Virology Journal, Virology Journal, Vol 17, Iss 1, Pp 1-9 (2020)
- Publication Year :
- 2020
- Publisher :
- Springer Science and Business Media LLC, 2020.
-
Abstract
- Background: The emergence of influenza viruses resistant to anti-influenza drugs is a threat to public health. The Korea Centers for Disease Control and Prevention operates the Korea Influenza and Respiratory Viruses Surveillance System (KINRESS) to monitor epidemic of influenza and Severe Acute Respiratory Infection (SARI) to identify mutated influenza viruses affecting drug resistance, pathogenesis, and transmission. Methods: Oropharyngeal swab samples were collected from KINRESS and SARI during the 2018-2019 season. The specimens confirmed influenza virus using real-time RT-PCR on inoculated MDCK cells. HA and NA sequences of the influenza viruses were analyzed for phylogeny and mutations. Neuraminidase inhibition and hemagglutination inhibition assays were utilized to characterize the isolates. Results: Two A(H1N1)pdm09 isolates harboring an H275Y substitution in the neuraminidase sequence were detected in patients with acute hematologic cancer. They had prolonged respiratory symptoms, with the virus present in the respiratory tract despite oseltamivir and peramivir treatment. Through the neuraminidase inhibition assay, both the viruses were found to be resistant to oseltamivir and peramivir, but not to zanamivir. Although hemagglutinin and neuraminidase phylogenetic analyses suggested that the two A(H1N1)pdm09 isolates were not identical, their antigenicity was similar to that of the 2018-19 influenza vaccine virus. Conclusions: Our data indicate the utility of monitoring influenza-infected immunocompromised patients in general hospitals for the early detection of emerging neuraminidase inhibitor-resistant viruses and maintaining continuous laboratory surveillance of patients with influenza-like illness in sentinel clinics to monitor the spread of such new variants. Finally, characterization of the virus can inform the assessment of risk for future epidemics and pandemics caused by drug-resistant influenza viruses.
- Subjects :
- 0301 basic medicine
viruses
Oropharynx
Guanidines
chemistry.chemical_compound
Influenza A Virus, H1N1 Subtype
H275Y
Zanamivir
Enzyme Inhibitors
Phylogeny
Neuraminidase inhibitor
virus diseases
Infectious Diseases
Immunocompromised patients
Female
medicine.drug
Adult
Oseltamivir
Influenza vaccine
medicine.drug_class
030106 microbiology
Acids, Carbocyclic
Neuraminidase
Hemagglutinin (influenza)
Biology
Antiviral Agents
lcsh:Infectious and parasitic diseases
Immunocompromised Host
03 medical and health sciences
Virology
Drug Resistance, Viral
Influenza, Human
Republic of Korea
medicine
Humans
lcsh:RC109-216
Hemagglutination assay
Research
Sequence Analysis, DNA
030104 developmental biology
Amino Acid Substitution
chemistry
Drug resistance
Mutation
biology.protein
Peramivir
Influenza virus
Subjects
Details
- ISSN :
- 1743422X
- Volume :
- 17
- Database :
- OpenAIRE
- Journal :
- Virology Journal
- Accession number :
- edsair.doi.dedup.....693ddd760fb3a0d6c358946752c48228
- Full Text :
- https://doi.org/10.1186/s12985-020-01375-1